References
- Fine NM, Davis MK, Anderson K, et al. Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis. Canadian Journal of Cardiology. 2020;36(3):322–334.
- Khanna S, Wen I, Bhat A, et al. The Role of Multimodality Imaging in the Diagnosis of Cardiac Amyloidosis: A Focused Update Frontiers in Cardiovascular Medicine. 2020;7:212.
- Kittleson MM, Maurer MS, Ambardekar AV, et al. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association. Circulation. 2020;142(1):7–22.
- Pun SC, Landau HJ, Riedel ER, et al. Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation. Journal of the American Society of Echocardiography. 2018;31(1):64–70.
- Nguyen HT, Nguyen CTH. Cardiac amyloidosis mimicking acute coronary syndrome: a case report and literature review. European Heart Journal - Case Reports. October 2020.
- Neben-Wittich MA, Wittich CM, Mueller PS, Larson DR, Gertz MA, Edwards WD. Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosis. The American Journal of Medicine. 2005;118(11):1287.
- Dorbala S, Vangala D, Bruyere J, et al. Coronary Microvascular Dysfunction Is Related to Abnormalities in Myocardial Structure and Function in Cardiac Amyloidosis. JACC: Heart Failure. 2014;2(4):358–367.
- Agha AM, Parwani P, Guha A, et al. Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis. Open heart. 2018;5(2):e000881–e000881.
- Quarta CC, Kruger JL, Falk RH. Cardiac Amyloidosis. Circulation. 2012;126(12):178–182.
- Phelan D, Collier P, Thavendiranathan P, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98(19):1442 – 1448.
- Knight DS, Zumbo G, Barcella W, et al. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles. JACC: Cardiovascular Imaging. 2019;12(5):823–833.
- Child N, Muhr T, Sammut E, et al. Prevalence of myocardial crypts in a large retrospective cohort study by cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance. 2014;16(1):66.
- Bodez D, Ternacle J, Guellich A, et al. Prognostic value of right ventricular systolic function in cardiac amyloidosis. Amyloid. 2016; 23(3):158–167.
- Dungu JN, Valencia O, Pinney JH, et al. CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis. JACC: Cardiovascular Imaging. 2014;7(2):133–142.
- Wan K, Sun J, Han Y, et al. Increased Prognostic Value of Query Amyloid Late Enhancement Score in Light-Chain Cardiac Amyloidosis. Circulation Journal. 2018;82(3):739–746.
- Siegismund, C.S., Escher, F., Lassner, D, et al. Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis. Eur J Heart Fail, 2018: 751–757.